MSN-SOLIFENACIN (Accelagen Pty Ltd)
Product name
MSN-SOLIFENACIN
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
96 working days (255)
Active ingredients
solifenacin succinate
Registration type
New generic medicine
Indication
MSN-SOLIFENACIN (film-coated tablet) is indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency or increased urinary frequency.